Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2.36M
-
Shares change
-
-111K
-
Total reported value, excl. options
-
$943K
-
Value change
-
-$17.8K
-
Number of buys
-
8
-
Number of sells
-
-11
-
Price
-
$0.40
Significant Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2024
35 filings reported holding IGC - IGC Pharma, Inc. - COM NEW as of Q1 2024.
IGC Pharma, Inc. - COM NEW (IGC) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.36M shares
.
Largest 10 shareholders include BlackRock Inc. (715K shares), VANGUARD GROUP INC (645K shares), GEODE CAPITAL MANAGEMENT, LLC (324K shares), RENAISSANCE TECHNOLOGIES LLC (141K shares), STATE STREET CORP (120K shares), DEARBORN PARTNERS LLC (117K shares), NORTHERN TRUST CORP (71.4K shares), GOLDMAN SACHS GROUP INC (65.5K shares), GROUP ONE TRADING, L.P. (37.3K shares), and TRUIST FINANCIAL CORP (36.7K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.